Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Esophageal Neoplasms 3 Lymphatic Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Recurrence 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Melanoma 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Fluorouracil 19 Oxaliplatin 17 Capecitabine 16 Leucovorin 14 Cisplatin 12 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Bevacizumab 10 Radiosurgery 9 Cetuximab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × TP protocol × Clear all

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡